HBV Genotype B/C and Response to Lamivudine Therapy: A Systematic Review

A number of nucleoside analogues such as lamivudine (LAM), actually used for the treatment of chronic hepatitis B, can suppress HBV DNA replication, improve transaminase level and liver histology, and enhance the rate of hepatitis B e antigen (HBeAg) clearance. The responses to LAM therapy involve H...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Xiu-Li, Li, Man, Zhang, Xiao-Lan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2013
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3863712/
https://www.ncbi.nlm.nih.gov/pubmed/24364035
http://dx.doi.org/10.1155/2013/672614

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3863712/
https://www.ncbi.nlm.nih.gov/pubmed/24364035
http://dx.doi.org/10.1155/2013/672614

Ejemplares similares